XML 80 R8.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash Flows from Operating Activities:      
Net income $ 827,543 $ 797,883 $ 771,312
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation & amortization 490,392 453,076 447,883
Gains on sales of assets and businesses, net of losses (7,540) (2,513) 0
Stock-based compensation expense 69,431 66,581 56,738
Costs related to extinguishment of debt 0 2,727 0
Provision for asset impairment 97,631 49,310 0
Changes in assets & liabilities, net of effects from acquisitions and dispositions:      
Accounts receivable (42,056) (42,239) (24,719)
Accrued interest 209 (4,478) 705
Accrued and deferred income taxes (25,194) (54,052) (6,405)
Other working capital accounts 39,664 24,696 (15,165)
Other assets and deferred charges (27,205) (31,429) (27,936)
Other 7,703 (1,536) 21,769
Accrued insurance expense, net of commercial premiums paid 105,672 92,863 102,595
Payments made in settlement of self-insurance claims (97,781) (76,147) (79,192)
Net cash provided by operating activities 1,438,469 1,274,742 1,247,585
Cash Flows from Investing Activities:      
Property and equipment additions, net of disposals (634,095) (664,962) (557,506)
Acquisition of property and businesses (8,005) (110,464) (22,878)
(Outflows) Inflows from foreign exchange contracts that hedge our net U.K. investment (19,763) 66,151 (64,333)
Proceeds received from sales of assets and businesses 9,450 13,502 108
Costs incurred for purchase and implementation of information technology applications (21,418) (36,243) (29,047)
Decrease (Increase) in capital reserves of commercial insurance subsidiary 0 100 (3,100)
Investment in, and advances to, joint venture and other (14,579) (15,331) (7,976)
Net cash used in investing activities (688,410) (747,247) (684,732)
Cash Flows from Financing Activities:      
Reduction of long-term debt (57,142) (830,496) (143,106)
Additional borrowings 39,220 791,247 41,100
Financing costs 0 (13,787) (76)
Repurchase of common shares (770,504) (397,425) (364,401)
Dividends paid (53,003) (37,342) (38,211)
Issuance of common stock 10,806 10,196 10,254
Profit distributions to noncontrolling interests (15,859) (14,595) (24,713)
Capital contributions from minority members 1,446 0 0
Net cash used in financing activities (845,036) (492,202) (519,153)
Effect of exchange rate changes on cash and cash equivalents 959 (2,905) 1,647
(Decrease) Increase in cash and cash equivalents (94,018) 32,388 45,347
Cash, cash equivalents and restricted cash, beginning of period 199,685 167,297 121,950
Cash, cash equivalents and restricted cash, end of period 105,667 199,685 167,297
Supplemental Disclosures of Cash Flow Information:      
Interest paid 157,406 150,293 135,533
Income taxes paid, net of refunds 260,622 293,837 370,855
Noncash purchases of property and equipment 63,514 77,674 82,496
Right-of-use assets obtained in exchange for lease obligations $ 383,857 $ 0 $ 0